KDIGO heat-map categoriesBiomarker1 paperHumans1LatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 11 in 12 monthsKidney360·7 hValidation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) PopulationCohort study of 4,304 peopleChronic kidney diseasePaper
Kidney360·7 hValidation of the Klinrisk CKD Progression Model in the Dapagliflozin and Prevention of Adverse Outcomes in CKD (DAPA-CKD) PopulationCohort study of 4,304 peopleChronic kidney diseasePaper